CLXN and breast cancer: Interestingly, eight genes (ID4, LTBP4, GPM6B, RGMA, EFCAB1, ALX4, OSR1 and PPARA) were confirmed to be down-expressed in breast cancer tissues, and associated with the overall survival time of breast cancer patients, as high expression of these genes correlate with an improved prognosis.